Market Research Industry Reports

Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The companys product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic bronchiectasis (BE) and cystic fibrosis (CF); ARD-1100, liposomal ciprofloxacin for the treatment of inhalation tularemia, anthrax infections, Q fever and pneumonic plague and ARD-1600, for the prevention and treatment of respiratory and other diseases in tobacco smokers through smoking cessation. Its proprietary pulmonary drug delivery platform, AERx, is customized for the delivery of drugs to the target along with liposomal formulations. Aradigm is headquartered in Hayward, California, the US.

Aradigm Corp Key Recent Developments

Mar 23,2018: Aradigm Reports Fourth Quarter 2017 And Full Year Financial Results
Feb 09,2018: Aradigm Announces Personnel Changes
Nov 02,2017: Aradigm Announces Third Quarter 2017 Financial Results
Oct 10,2017: Aradigm Regains Compliance with NASDAQ Listing Requirements
Aug 10,2017: Aradigm Announces Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Aradigm Corp - Key Facts 5
Aradigm Corp - Key Employees 6
Aradigm Corp - Key Employee Biographies 7
Aradigm Corp - Major Products and Services 8
Aradigm Corp - History 9
Aradigm Corp - Company Statement 11
Aradigm Corp - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Company Overview 14
Aradigm Corp - Business Description 15
Aradigm Corp - Corporate Strategy 16
Aradigm Corp - SWOT Analysis 17
SWOT Analysis - Overview 17
Aradigm Corp - Strengths 17
Aradigm Corp - Weaknesses 18
Aradigm Corp - Opportunities 19
Aradigm Corp - Threats 20
Aradigm Corp - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Companys Lifesciences Financial Deals and Alliances 28
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Aradigm Corp, Recent Deals Summary 30
Section 5 Companys Recent Developments 31
Feb 09, 2018: Aradigm Announces Personnel Changes 31
Nov 02, 2017: Aradigm Announces Third Quarter 2017 Financial Results 32
Oct 10, 2017: Aradigm Regains Compliance with NASDAQ Listing Requirements 33
Aug 10, 2017: Aradigm Announces Second Quarter 2017 Financial Results 34
May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 35
Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 36
Section 6 Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List Of Tables

List of Tables
Aradigm Corp, Key Facts 5
Aradigm Corp, Key Employees 6
Aradigm Corp, Key Employee Biographies 7
Aradigm Corp, Major Products and Services 8
Aradigm Corp, History 9
Aradigm Corp, Subsidiaries 13
Aradigm Corp, Key Competitors 21
Aradigm Corp, Ratios based on current share price 22
Aradigm Corp, Annual Ratios 23
Aradigm Corp, Annual Ratios (Cont...1) 24
Aradigm Corp, Interim Ratios 26
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Aradigm Corp, Recent Deals Summary 30
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List Of Figures

List of Figures
Aradigm Corp, Performance Chart (2013 - 2017) 25
Aradigm Corp, Ratio Charts 27
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Aradigm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Aradigm Corp (ARDM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The companys product pipeline includes Pulmaquin (ARD-3150)

USD 250View Report

Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review

Aradigm Corp (ARDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125View Report

Aradigm Corp (ARDM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The companys product pipeline includes Pulmaquin (ARD-3150)

USD 250View Report

Aradigm Corporation Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Aradigm Corporation Company Profile is a detailed strategic and analytical report on Aradigm Corporation. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Jul 2018
No. of Pages :41
Country :United States of America
Category :Swot Analysis
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube